Effect of warfarin sodium therapy on excretion of 4-carboxy-L-glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressiva.

Moore, S E

Effect of warfarin sodium therapy on excretion of 4-carboxy-L-glutamic acid in scleroderma, dermatomyositis, and myositis ossificans progressiva. [electronic resource] - Arthritis and rheumatism Mar 1986 - 344-51 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

0004-3591

10.1002/art.1780290306 doi


Adult
Bone and Bones--diagnostic imaging
Calcium--urine
Carbon Radioisotopes
Chromatography, High Pressure Liquid
Cyclic AMP--urine
Dermatomyositis--urine
Female
Follow-Up Studies
Glutamates--urine
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Myositis Ossificans--urine
Phosphorus--urine
Radiography
Radionuclide Imaging
Scleroderma, Systemic--urine
Warfarin--adverse effects